Aspects physiopathologiques cliniques et thérapeutiques de la maladie de Darier [Clinical, therapeutic and pathophysiological aspects of Darier's disease]

Détails

Ressource 1Demande d'une copie Sous embargo jusqu'au 27/09/2025.
Accès restreint UNIL
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_B50E9268AF6F
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Aspects physiopathologiques cliniques et thérapeutiques de la maladie de Darier [Clinical, therapeutic and pathophysiological aspects of Darier's disease]
Périodique
Revue medicale suisse
Auteur⸱e⸱s
Bernard P., Blanchard M., Morren M.A., Guenova E.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
27/03/2024
Peer-reviewed
Oui
Volume
20
Numéro
867
Pages
659-663
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Résumé
Darier Disease is a rare autosomal dominant inherited skin disorder classified as an acantholytic dermatosis. It manifests around puberty as brownish keratotic papules of skin folds and seborrheic areas, associated with onychopathy and mucosal involvementand have a chronic relapsing-remitting course with frequent exacerbations triggered by sun exposure, heat, friction, or infections. Darier patients have an increased risk of neuropsychiatric disorders, type 1 diabetes and heart failure. Short-term management relies on antibiotics/antiviral, topical corticosteroids and/or retinoids. Moisturizers, sun protection and avoiding triggers are essential for long-term management. Conventional long-term treatment is not standardized and many topical treatments, physical and surgical measures and systemic treatments are described in the literature.
Mots-clé
Humans, Darier Disease/therapy, Darier Disease/drug therapy, Skin, Retinoids/therapeutic use, Anti-Bacterial Agents/therapeutic use
Pubmed
Création de la notice
05/04/2024 9:40
Dernière modification de la notice
06/04/2024 7:34
Données d'usage